Literature DB >> 16866779

Expression of iNOS mRNA associated with suppression of colonic contraction in rat colitis.

S Lundberg1, M Holst, P M Hellström.   

Abstract

AIM: Nitric oxide (NO) synthesis and inducible NO synthase (NOS) expression are increased in colon of patients with inflammatory bowel disease (IBD) and associated with decreased contractility. The aim was to investigate which subtype of NOS that is activated in experimental colitis.
METHODS: Experimental colitis was induced in Sprague-Dawley rats by Escherichia coli endotoxin. Expression of different subtypes of NOS was compared in normal and inflamed colon using reverse transcriptase-polymerase chain reaction. In organ baths, isometric contractile responses to acetylcholine (ACh) were studied in the colon, before and after incubation with the NOS inhibitor; N(omega)-nitro-L-arginine methyl ester (L-NAME) and NO donor glyceryl trinitrate.
RESULTS: Inflammation decreased colonic contraction to ACh from a pD(2) value of 7.09 +/- 0.16 to 5.30 +/- 0.17 (P < 0.001), and reduced maximal response to ACh. Pre-treatment with L-NAME reversed contractility and shifted the pD(2) for ACh from 5.30 +/- 0.17 to 6.60 +/- 0.19 (P < 0.001) along with a normalized contraction efficacy. RT-PCR product of iNOS was obtained only in rats treated with endotoxin.
CONCLUSION: Expression of iNOS is increased in inflamed colonic tissue. The induced overproduction of NO is likely to be responsible for the decreased motility in colitis where NO is suggested to exert a suppressive tone on colonic contractility, which is reversed by blockade of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16866779     DOI: 10.1111/j.1748-1716.2006.01576.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  11 in total

1.  Tumor necrosis factor-neuropeptide Y cross talk regulates inflammation, epithelial barrier functions, and colonic motility.

Authors:  Bindu Chandrasekharan; Sabrina Jeppsson; Stefan Pienkowski; Denise D Belsham; Shanthi V Sitaraman; Didier Merlin; Efi Kokkotou; Asma Nusrat; Malu G Tansey; Shanthi Srinivasan
Journal:  Inflamm Bowel Dis       Date:  2013-11       Impact factor: 5.325

2.  Basal cGMP regulates the resting pacemaker potential frequency of cultured mouse colonic interstitial cells of Cajal.

Authors:  Pawan Kumar Shahi; Seok Choi; Yu Jin Jeong; Chan Guk Park; Insuk So; Jae Yeoul Jun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-28       Impact factor: 3.000

3.  Evaluating the potential role of nitric oxide as a mediator of hydrostatic edema mediated intestinal contractile dysfunction.

Authors:  Shinil K Shah; Hasen Xue; Fernando Jimenez; Alexander Y Kots; Byung-Kwon Choi; Karen S Uray; Peter A Walker; Stacey D Moore-Olufemi; Natalia Velez; Randolph H Stewart; Glen A Laine; Charles S Cox
Journal:  J Surg Res       Date:  2010-03-19       Impact factor: 2.192

Review 4.  Resuscitation-induced intestinal edema and related dysfunction: state of the science.

Authors:  Shinil K Shah; Karen S Uray; Randolph H Stewart; Glen A Laine; Charles S Cox
Journal:  J Surg Res       Date:  2009-09-29       Impact factor: 2.192

5.  Neuronal activation and plasticity in Schistosoma mansoni infected mice.

Authors:  Faiza B Abdu
Journal:  Saudi J Biol Sci       Date:  2012-07-22       Impact factor: 4.219

6.  Wnt pathway-related gene expression in inflammatory bowel disease.

Authors:  Joann You; Anthony V Nguyen; C Gregory Albers; Fritz Lin; Randall F Holcombe
Journal:  Dig Dis Sci       Date:  2007-10-16       Impact factor: 3.199

7.  The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis.

Authors:  Aishah Al-Jarallah; Mabayoje Oriowo
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

8.  Interaction between the Renin-Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of Colitis.

Authors:  Mariana Ferreira-Duarte; Tiago Rodrigues-Pinto; Teresa Sousa; Miguel A Faria; Maria Sofia Rocha; Daniela Menezes-Pinto; Marisa Esteves-Monteiro; Fernando Magro; Patrícia Dias-Pereira; Margarida Duarte-Araújo; Manuela Morato
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

9.  Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model.

Authors:  Erdem Koçak; Erdem Akbal; Adnan Taş; Seyfettin Köklü; Gökhan Karaca; Murat Can; Bahadir Kösem; Hüseyin Üstün
Journal:  Saudi J Gastroenterol       Date:  2013 May-Jun       Impact factor: 2.485

Review 10.  Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions.

Authors:  Jiten Desai; Mohamed Elnaggar; Ahmed A Hanfy; Rajkumar Doshi
Journal:  Clin Exp Gastroenterol       Date:  2020-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.